WellPoint buying managed care firm for $4.9B

Back to TopCommentsE-mailPrintBookmark and Share

Indianapolis-based WellPoint Inc. agreed to buy Amerigroup Corp. for $4.9 billion in cash to expand in managed care for poor, elderly patients in the Medicare and Medicaid programs.

Amerigroup stockholders will receive $92 a share, the companies said in a statement Monday morning. The price is 43 percent above the closing level of Amerigroup in New York Stock Exchange trading on Friday.

“We believe that this combination will create an industry leader in the government sector serving Medicaid and Medicare enrolees,” WellPoint CEO Angela Braly said in the statement.

The acquisition would make WellPoint the top private manager of Medicaid benefits in the United States, with 4.5 million members in the government-sponsored programs.

The deal is expected to add to WellPoint's 2013 earnings per share and add more than $1 per share by 2015. The company is maintaining its 2012 earnings outlook.

Buying Virginia-based Amerigroup is the latest move by WellPoint  to adapt to the shifting health care landscape. Company officials have said they expected the industry to change dramatically whether or not the U.S. Supreme Court upheld health care reform. The court upheld the bulk of the law late last month.

The Amerigroup acquisition should be closed in the first quarter of 2013, the companies said. WellPoint will pay with cash on hand, commercial paper, and by selling new debt. The companies plan a Monday morning conference call to discuss the deal.

This story will be updated.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ